Ludo Van Den Bosch

Ludo Van Den Bosch is a co-founder of Augustine Therapeutics, a Belgian biotech developing treatments for neuromuscular and neurodegenerative diseases.

Overview

Co-founded Augustine Therapeutics alongside Bart De Strooper and Joris De Wit, researchers with strong academic credentials in neuroscience. The company raised EUR 77.7M in a Series A round in H1 2025, one of the larger biotech rounds in recent Belgian history, with PMV among the backers.

Career history

  1. FounderAugustine Therapeutics

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.